Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
147M
-
Number of holders
-
1047
-
Total 13F shares, excl. options
-
129M
-
Shares change
-
-1.89M
-
Total reported value, excl. options
-
$31.6B
-
Value change
-
-$521M
-
Put/Call ratio
-
1
-
Number of buys
-
381
-
Number of sells
-
-570
-
Price
-
$244.86
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q4 2020
1,266 filings reported holding BIIB - BIOGEN INC. - COM as of Q4 2020.
BIOGEN INC. - COM (BIIB) has 1,047 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 129M shares
of 147M outstanding shares and own 87.92% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (15.8M shares), BlackRock Inc. (13.4M shares), VANGUARD GROUP INC (11.9M shares), STATE STREET CORP (6.99M shares), WELLINGTON MANAGEMENT GROUP LLP (5.78M shares), Clearbridge Investments, LLC (3.6M shares), RENAISSANCE TECHNOLOGIES LLC (3.04M shares), JPMORGAN CHASE & CO (2.91M shares), GEODE CAPITAL MANAGEMENT, LLC (2.76M shares), and NORTHERN TRUST CORP (2.2M shares).
This table shows the top 1047 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.